The Future of Cell Therapy Release Testing: Automated QC for High-Throughput, Commercial-Scale Manufacturing
- Demonstrating how batchable QC workflows deliver order-of-magnitude increases in release testing throughput and significantly reduce hands-on time, transforming QC into a scalable enabler of commercial CAR-T manufacturing
- Showcasing, as an example, a fully automated flow cytometry assay, from sample barcode scanning and preparation through data capture, analysis, and COA sign-off
- Highlighting a regulatory-ready data strategy that reduces risk, increases consistency, and enables faster, more reliable product release